News Image

Theravance Biopharma to Host Virtual KOL Investor Event to Review Ampreloxetine Phase 3 Clinical Development Program, Ahead of Topline Data in Q1 2026, on December 8, 2025

Provided By PR Newswire

Last update: Nov 20, 2025

DUBLIN, Nov. 20, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) today announced that it will host a virtual key opinion leader (KOL) investor event on Monday, December 8, 2025 at 10:30 AM ET. To register, click here.

Read more at prnewswire.com

THERAVANCE BIOPHARMA INC

NASDAQ:TBPH (12/22/2025, 3:22:56 PM)

18.91

+0.12 (+0.64%)



Find more stocks in the Stock Screener

Follow ChartMill for more